NewslettersMesenchymal Cell NewsAdipokines at the Crossroads of Obesity and Mesenchymal Stem Cell TherapyBy lbeveridge - February 7, 20230173The authors summarize recent advances in the use of MSC for the treatment of obesity-associated diseases to support the hypothesis that adipokines modulate the benefits of MSC therapy in obese patients.[Experimental & Molecular Medicine]Full Article